The role of different serotonin receptor subtypes in seizure susceptibility

Experimental Brain Research

Volumn 232, Issue 2, 2014, Pages 347-367

  Gharedaghi, Mohammad Hadi ^a,b,c   Seyedabadi, Mohammad ^d   Ghia, Jean Eric ^e   Dehpour, Ahmad Reza ^a,b   Rahimian, Reza ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d BUSHEHR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Epilepsy; Seizure; Serotonin

Indexed keywords

ANIMALS; DISEASE SUSCEPTIBILITY; HUMANS; RECEPTORS, SEROTONIN; SEIZURES; SEROTONIN;

EID: 84893842656     PISSN: 00144819     EISSN: 14321106     Source Type: Journal    
DOI: 10.1007/s00221-013-3757-0     Document Type: Review

References (179)

1. Agosti RM (2007) 5HT1F- and 5HT7-receptor agonists for the treatment of migraines. CNS Neurol Disord: Drug Targets 6(4):235-237 (Pubitemid 47232932)
2. Alex KD, Yavanian GJ, McFarlane HG, Pluto CP, Pehek EA (2005) Modulation of dopamine release by striatal 5-HT2C receptors. Synapse 55(4):242-251. doi: 10.1002/syn.20109 (Pubitemid 40256305)
3. al-Tajir G, Chandler CJ, Starr BS, Starr MS (1990) Opposite effects of stimulation of D1 and D2 dopamine receptors on the expression of motor seizures in mouse and rat. Neuropharmacology 29(7):657-661 (Pubitemid 20225079)
4. Andrade R, Malenka RC, Nicoll RA (1986) A G protein couples serotonin and GABAB receptors to the same channels in hippocampus. Science 234(4781):1261-1265 (Pubitemid 17232369)
5. Anlezark GM, Meldrum BS (1975) Effects of apomorphine, ergocornine and piribedil on audiogenic seizures in DBA/2 mice. Br J Pharmacol 53(3):419-421
6. Annedi SC, Ramnauth J, Maddaford SP, Renton P, Rakhit S, Mladenova G, Dove P, Silverman S, Andrews JS, Felice MD, Porreca F (2012) Discovery of cis-N-(1-(4-(methylamino)cyclohexyl)indolin-6-yl)thiophene-2-carboximidamide: a 1,6-disubstituted indoline derivative as a highly selective inhibitor of human neuronal nitric oxide synthase (nNOS) without any cardiovascular liabilities. J Med Chem 55(2):943-955. doi: 10.1021/jm201564u
7. Applegate CD, Tecott LH (1998) Global increases in seizure susceptibility in mice lacking 5-HT2C receptors: a behavioral analysis. Exp Neurol 154(2):522-530. doi: 10.1006/exnr.1998.6901 (Pubitemid 29044221)
8. Archer T (1987) 5-Hydroxytryptamine antagonists and the 5-methoxy-N, N-dimethyltryptamine-induced changes of post decapitation convulsions. Pharmacol Toxicol 60(1):37-42 (Pubitemid 17042683)
9. Artigas F, Perez V, Alvarez E (1994) Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors. Arch Gen Psychiatry 51(3):248-251 (Pubitemid 24081512)
10. Bagdy G, Kecskemeti V, Riba P, Jakus R (2007) Serotonin and epilepsy. J Neurochem 100(4):857-873. doi: 10.1111/j.1471-4159.2006.04277.x (Pubitemid 46213913)
11. Bahremand A, Payandemehr B, Rahimian R, Ziai P, Pourmand N, Loloee S, Ebrahimi A, Ghasemi A, Fakhfouri G, Ghasemi M, Dehpour AR (2011) The role of 5-HT(3) receptors in the additive anticonvulsant effects of citalopram and morphine on pentylenetetrazole-induced clonic seizures in mice. Epilepsy Behav 21(2):122-127. doi: 10.1016/j.yebeh.2011.03.010
12. Balakrishnan S, Bhargava VK, Pandhi P (2000) Anticonvulsant profile of ondansetron in rats. Epilepsy Behav 1(1):22-26. doi: 10.1006/ebeh.2000.0028
13. Barnes NM, Sharp T (1999) A review of central 5-HT receptors and their function. Neuropharmacology 38(8):1083-1152 (Pubitemid 29292403)
14. Barnes NM, Hales TG, Lummis SC, Peters JA (2009) The 5-HT3 receptor-the relationship between structure and function. Neuropharmacology 56(1):273-284. doi: 10.1016/j.neuropharm.2008.08.003
15. Bercovici E, Cortez MA, Snead OC 3rd (2007) 5-HT2 modulation of AY-9944 induced atypical absence seizures. Neurosci Lett 418(1):13-17. doi: 10.1016/j.neulet.2007.02.062 (Pubitemid 46628853)
16. Bijak M, Misgeld U (1997) Effects of serotonin through serotonin1A and serotonin4 receptors on inhibition in the guinea-pig dentate gyrus in vitro. Neuroscience 78(4):1017-1026 (Pubitemid 27223708)
17. Bijak M, Tokarski K, Maj J (1997) Repeated treatment with antidepressant drugs induces subsensitivity to the excitatory effect of 5-HT4 receptor activation in the rat hippocampus. Naunyn Schmiedebergs Arch Pharmacol 355(1):14-19 (Pubitemid 27008447)
18. Bijak M, Zahorodna A, Tokarski K (2001) Opposite effects of antidepressants and corticosterone on the sensitivity of hippocampal CA1 neurons to 5-HT1A and 5-HT4 receptor activation. Naunyn Schmiedebergs Arch Pharmacol 363(5):491-498 (Pubitemid 32417806)
19. Blier P, Bergeron R (1995) Effectiveness of pindolol with selected antidepressant drugs in the treatment of major depression. J Clin Psychopharmacol 15(3):217-222
20. Bonaventure P, Nepomuceno D, Hein L, Sutcliffe JG, Lovenberg T, Hedlund PB (2004) Radioligand binding analysis of knockout mice reveals 5-hydroxytryptamine(7) receptor distribution and uncovers 8-hydroxy-2-(di-n- propylamino)tetralin interaction with alpha(2) adrenergic receptors. Neuroscience 124(4):901-911. doi: 10.1016/j.neuroscience.2004.01.014 (Pubitemid 38328779)
21. Bourne JA (2001) SCH 23390: the first selective dopamine D1-like receptor antagonist. CNS Drug Rev 7(4):399-414 (Pubitemid 34263874)
22. Bourson A, Kapps V, Zwingelstein C, Rudler A, Boess FG, Sleight AJ (1997) Correlation between 5-HT7 receptor affinity and protection against sound-induced seizures in DBA/2 J mice. Naunyn Schmiedebergs Arch Pharmacol 356(6):820-826 (Pubitemid 27525082)
23. Brady CA, Dover TJ, Massoura AN, Princivalle AP, Hope AG, Barnes NM (2007) Identification of 5-HT3A and 5-HT3B receptor subunits in human hippocampus. Neuropharmacology 52(5):1284-1290. doi: 10.1016/j.neuropharm.2007. 01.009 (Pubitemid 46546407)
24. Brennan TJ, Seeley WW, Kilgard M, Schreiner CE, Tecott LH (1997) Sound-induced seizures in serotonin 5-HT2c receptor mutant mice. Nat Genet 16(4):387-390. doi: 10.1038/ng0897-387 (Pubitemid 27323307)
25. Bubar MJ, Cunningham KA (2006) Serotonin 5-HT2A and 5-HT2C receptors as potential targets for modulation of psychostimulant use and dependence. Curr Top Med Chem 6(18):1971-1985 (Pubitemid 44524471)
26. Burke K, Chandler CJ, Starr BS, Starr MS (1990) Seizure promotion and protection by D-1 and D-2 dopaminergic drugs in the mouse. Pharmacol Biochem Behav 36(4):729-733 (Pubitemid 20272284)
27. Buzsaki G (1991) The thalamic clock: emergent network properties. Neuroscience 41(2-3):351-364
28. Cagnotto A, Crespi D, Mancini L, Manzoni C, Presti ML, Gariboldi M, Vezzani A, Mennini T (1998) Lasting increase in serotonin 5-HT1A but not 5-HT4 receptor subtypes in the kindled rat dentate gyrus: dissociation from local presynaptic effects. J Neurochem 70(2):850-857 (Pubitemid 28079377)
29. Clinckers R, Smolders I, Meurs A, Ebinger G, Michotte Y (2004a) Anticonvulsant action of GBR-12909 and citalopram against acute experimentally induced limbic seizures. Neuropharmacology 47(7):1053-1061. doi: 10.1016/j.neuropharm.2004.07.032 (Pubitemid 39535844)
30. Clinckers R, Smolders I, Meurs A, Ebinger G, Michotte Y (2004b) Anticonvulsant action of hippocampal dopamine and serotonin is independently mediated by D and 5-HT receptors. J Neurochem 89(4):834-843. doi: 10.1111/j.1471-4159.2004.02355.x (Pubitemid 38684731)
31. Coenen AM, Ates N, Skarsfeldt T, van Luijtelaar EL (1995) Effects of sertindole on sleep-wake states, electroencephalogram, behavioral patterns, and epileptic activity of rats. Pharmacol Biochem Behav 51(2-3):353-357
32. Compan V, Zhou M, Grailhe R, Gazzara RA, Martin R, Gingrich J, Dumuis A, Brunner D, Bockaert J, Hen R (2004) Attenuated response to stress and novelty and hypersensitivity to seizures in 5-HT4 receptor knock-out mice. J Neurosci 24(2):412-419. doi: 10.1523/JNEUROSCI.2806-03.2004 (Pubitemid 38112372)
33. Costall B, Jones BJ, Kelly ME, Naylor RJ, Onaivi ES, Tyers MB (1990) Ondansetron inhibits a behavioural consequence of withdrawing from drugs of abuse. Pharmacol Biochem Behav 36(2):339-344 (Pubitemid 20189794)
34. Costall B, Domeney AM, Kelly ME, Tomkins DM, Naylor RJ, Wong EH, Smith WL, Whiting RL, Eglen RM (1993) The effect of the 5-HT3 receptor antagonist, RS-42358-197, in animal models of anxiety. Eur J Pharmacol 234(1):91-99 (Pubitemid 23093409)
35. Dawson LA, Nguyen HQ (2000) The role of 5-HT(1A) and 5-HT(1B/1D) receptors on the modulation of acute fluoxetine-induced changes in extracellular 5-HT: the mechanism of action of (±)pindolol. Neuropharmacology 39(6):1044-1052 (Pubitemid 30155712)
36. De Deurwaerdere P, Navailles S, Berg KA, Clarke WP, Spampinato U (2004) Constitutive activity of the serotonin 2C receptor inhibits in vivo dopamine release in the rat striatum and nucleus accumbens. J Neurosci 24(13):3235-3241. doi: 10.1523/JNEUROSCI.0112-04.2004 (Pubitemid 38451889)
37. Deransart C, Riban V, Le B, Marescaux C, Depaulis A (2000) Dopamine in the striatum modulates seizures in a genetic model of absence epilepsy in the rat. Neuroscience 100(2):335-344
38. Di Matteo V, Di Giovanni G, Di Mascio M, Esposito E (1999) SB 242084, a selective serotonin2C receptor antagonist, increases dopaminergic transmission in the mesolimbic system. Neuropharmacology 38(8):1195-1205 (Pubitemid 29292408)
39. Di Matteo V, De Blasi A, Di Giulio C, Esposito E (2001) Role of 5-HT(2C) receptors in the control of central dopamine function. Trends Pharmacol Sci 22(5):229-232 (Pubitemid 32411523)
40. Didelot A, Ryvlin P, Lothe A, Merlet I, Hammers A, Mauguiere F (2008) PET imaging of brain 5-HT1A receptors in the preoperative evaluation of temporal lobe epilepsy. Brain 131(Pt 10):2751-2764. doi: 10.1093/brain/awn220
41. Dreshfield LJ, Wong DT, Perry KW, Engleman EA (1996) Enhancement of fluoxetine-dependent increase of extracellular serotonin (5-HT) levels by (-)-pindolol, an antagonist at 5-HT1A receptors. Neurochem Res 21(5):557-562
42. Eison AS, Wright RN, Freeman RP, Gylys JA (1993) 5-HT-dependent myoclonus in guinea pigs: mediation through 5-HT1A-5-HT2 receptor interaction. Brain Res Bull 30(5-6):687-689 (Pubitemid 23086091)
43. Faerber L, Drechsler S, Ladenburger S, Gschaidmeier H, Fischer W (2007) The neuronal 5-HT3 receptor network after 20 years of research-evolving concepts in management of pain and inflammation. Eur J Pharmacol 560(1):1-8. doi: S0014-10.1016/j.ejphar.2007.01.028
44. Filakovszky J, Gerber K, Bagdy G (1999) A serotonin-1A receptor agonist and an N-methyl-d-aspartate receptor antagonist oppose each others effects in a genetic rat epilepsy model. Neurosci Lett 261(1-2):89-92 (Pubitemid 29100083)
45. Filakovszky J, Kantor S, Halasz P, Bagdy G (2001) 8-OH-DPAT and MK-801 affect epileptic activity independently of vigilance. Neurochem Int 38(7):551-556 (Pubitemid 32268619)
46. Fletcher PJ, Grottick AJ, Higgins GA (2002) Differential effects of the 5-HT(2A) receptor antagonist M100907 and the 5-HT(2C) receptor antagonist SB242084 on cocaine-induced locomotor activity, cocaine self-administration and cocaine-induced reinstatement of responding. Neuropsychopharmacology 27(4):576-586. doi: 10.1016/S0893-133X(02)00342-1
47. Gariboldi M, Tutka P, Samanin R, Vezzani A (1996) Stimulation of 5-HT1A receptors in the dorsal hippocampus and inhibition of limbic seizures induced by kainic acid in rats. Br J Pharmacol 119(5):813
48. Genkova-Papazova M, Lazarova-Bakarova M, Petkov VD (1994) The 5-HT2 receptor antagonist ketanserine prevents electroconvulsive shock- and clonidine-induced amnesia. Pharmacol Biochem Behav 49(4):849-852 (Pubitemid 24376020)
49. George M, Al-Duaij N, O'Donnell KA, Shannon MW (2008) Obtundation and seizure following ondansetron overdose in an infant. Clin Toxicol (Phila) 46(10):1064-1066. doi: 10.1080/15563650802304401
50. Gerber K, Filakovszky J, Halasz P, Bagdy G (1998) The 5-HT1A agonist 8-OH-DPAT increases the number of spike-wave discharges in a genetic rat model of absence epilepsy. Brain Res 807(1-2):243-245 (Pubitemid 29005263)
51. Gholipour T, Ghasemi M, Riazi K, Ghaffarpour M, Dehpour AR (2010) Seizure susceptibility alteration through 5-HT(3) receptor: modulation by nitric oxide. Seizure 19(1):17-22. doi: 10.1016/j.seizure.2009.10.006
52. Gill CH, Soffin EM, Hagan JJ, Davies CH (2002) 5-HT7 receptors modulate synchronized network activity in rat hippocampus. Neuropharmacology 42(1):82-92 (Pubitemid 34062824)
53. Giovacchini G, Toczek MT, Bonwetsch R, Bagic A, Lang L, Fraser C, Reeves-Tyer P, Herscovitch P, Eckelman WC, Carson RE, Theodore WH (2005) 5-HT 1A receptors are reduced in temporal lobe epilepsy after partial-volume correction. J Nucl Med 46(7):1128-1135 (Pubitemid 43741074)
54. Gobert A, Millan MJ (1999) Serotonin (5-HT)2A receptor activation enhances dialysate levels of dopamine and noradrenaline, but not 5-HT, in the frontal cortex of freely-moving rats. Neuropharmacology 38(2):315-317 (Pubitemid 29073553)
55. Gobert A, Dekeyne A, Millan MJ (2000) The ability of WAY100,635 to potentiate the neurochemical and functional actions of fluoxetine is enhanced by co-administration of SB224,289, but not BRL15572. Neuropharmacology 39(9):1608-1616 (Pubitemid 30330877)
56. Goodman LS, Gilman A, Brunton LL, Lazo JS, Parker KL (2006) Goodman and Gilman's the pharmacological basis of therapeutics, 11th edn. McGraw-Hill, New York
57. Goodman LS, Brunton LL, Chabner B, Knollmann BC (2011) Goodman and Gilman's pharmacological basis of therapeutics, 12th edn. McGraw-Hill, New York
58. Graf M, Jakus R, Kantor S, Levay G, Bagdy G (2004) Selective 5-HT1A and 5-HT7 antagonists decrease epileptic activity in the WAG/Rij rat model of absence epilepsy. Neurosci Lett 359(1-2):45-48. doi: 10.1016/j.neulet.2004.01. 072 (Pubitemid 38446635)
59. Grant KA, Hellevuo K, Tabakoff B (1994) The 5-HT3 antagonist MDL-72222 exacerbates ethanol withdrawal seizures in mice. Alcohol Clin Exp Res 18(2):410-414
60. Hagan JJ, Hatcher JP, Slade PD (1995) The role of 5-HT1D and 5-HT1A receptors in mediating 5-hydroxytryptophan induced myoclonic jerks in guinea pigs. Eur J Pharmacol 294(2-3):743-751
61. Hahn A, Nics L, Baldinger P, Ungersbock J, Dolliner P, Frey R, Birkfellner W, Mitterhauser M, Wadsak W, Karanikas G, Kasper S, Lanzenberger R (2012) Combining image-derived and venous input functions enables quantification of serotonin-1A receptors with [carbonyl-11C]WAY-100635 independent of arterial sampling. Neuroimage 62(1):199-206. doi: 10.1016/j.neuroimage.2012.04.047
62. Hapfelmeier G, Tredt C, Haseneder R, Zieglgansberger W, Eisensamer B, Rupprecht R, Rammes G (2003) Co-expression of the 5-HT3B serotonin receptor subunit alters the biophysics of the 5-HT3 receptor. Biophys J 84(3):1720-1733. doi: 10.1016/S0006-3495(03)74980-7 (Pubitemid 36322935)
63. Hasler G, Bonwetsch R, Giovacchini G, Toczek MT, Bagic A, Luckenbaugh DA, Drevets WC, Theodore WH (2007) 5-HT1A receptor binding in temporal lobe epilepsy patients with and without major depression. Biol Psychiatry 62(11):1258-1264. doi: 10.1016/j.biopsych.2007.02.015 (Pubitemid 350060892)
64. Hedges D, Jeppson K, Whitehead P (2003) Antipsychotic medication and seizures: a review. Drugs Today (Barc) 39(7):551-557 (Pubitemid 37187418)
65. Hidaka N, Suemaru K, Araki H (2010) Serotonin-dopamine antagonism ameliorates impairments of spontaneous alternation and locomotor hyperactivity induced by repeated electroconvulsive seizures in rats. Epilepsy Res 90(3):221-227. doi: 10.1016/j.eplepsyres.2010.05.004
66. Hirst WD, Stean TO, Rogers DC, Sunter D, Pugh P, Moss SF, Bromidge SM, Riley G, Smith DR, Bartlett S, Heidbreder CA, Atkins AR, Lacroix LP, Dawson LA, Foley AG, Regan CM, Upton N (2006) SB-399885 is a potent, selective 5-HT6 receptor antagonist with cognitive enhancing properties in aged rat water maze and novel object recognition models. Eur J Pharmacol 553(1-3):109-119. doi: 10.1016/j.ejphar.2006.09.049 (Pubitemid 44779592)
67. Hjorth S (1996) (-)-Pindolol, but not buspirone, potentiates the citalopram-induced rise in extracellular 5-hydroxytryptamine. Eur J Pharmacol 303(3):183-186 (Pubitemid 26200669)
68. Hjorth S, Auerbach SB (1996) 5-HT1A autoreceptors and the mode of action of selective serotonin reuptake inhibitors (SSRI). Behav Brain Res 73(1-2):281-283
69. Hornung JP, Celio MR (1992) The selective innervation by serotoninergic axons of calbindin-containing interneurons in the neocortex and hippocampus of the marmoset. J Comp Neurol 320(4):457-467. doi: 10.1002/cne.903200404
70. Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GR, Mylecharane EJ, Saxena PR, Humphrey PP (1994) International union of pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol Rev 46(2):157-203 (Pubitemid 24185150)
71. Hughes ZA, Starr KR, Scott CM, Newson MJ, Sharp T, Watson JM, Hagan JJ, Dawson LA (2007) Simultaneous blockade of 5-HT1A/B receptors and 5-HT transporters results in acute increases in extracellular 5-HT in both rats and guinea pigs: in vivo characterization of the novel 5-HT1A/B receptor antagonist/5-HT transport inhibitor SB-649915-B. Psychopharmacology 192(1):121-133. doi: 10.1007/s00213-006-0691-x (Pubitemid 46673892)
72. Humphrey PP, Hartig P, Hoyer D (1993) A proposed new nomenclature for 5-HT receptors. Trends Pharmacol Sci 14(6):233-236 (Pubitemid 23172506)
73. Ishibashi T, Horisawa T, Tokuda K, Ishiyama T, Ogasa M, Tagashira R, Matsumoto K, Nishikawa H, Ueda Y, Toma S, Oki H, Tanno N, Saji I, Ito A, Ohno Y, Nakamura M (2010) Pharmacological profile of lurasidone, a novel antipsychotic agent with potent 5-hydroxytryptamine 7 (5-HT7) and 5-HT1A receptor activity. J Pharmacol Exp Ther 334(1):171-181. doi: 10.1124/jpet.110.167346
74. Jakala P, Sirvio J, Koivisto E, Bjorklund M, Kaukua J, Riekkinen P Jr (1995) Modulation of rat neocortical high-voltage spindle activity by 5-HT1/5-HT2 receptor subtype specific drugs. Eur J Pharmacol 282(1-3):39-55
75. Jakus R, Graf M, Juhasz G, Gerber K, Levay G, Halasz P, Bagdy G (2003) 5-HT2C receptors inhibit and 5-HT1A receptors activate the generation of spike-wave discharges in a genetic rat model of absence epilepsy. Exp Neurol 184(2):964-972. doi: 10.1016/S0014-4886(03)00352-2 (Pubitemid 38182825)
76. Jakus R, Graf M, Ando RD, Balogh B, Gacsalyi I, Levay G, Kantor S, Bagdy G (2004) Effect of two noncompetitive AMPA receptor antagonists GYKI 52466 and GYKI 53405 on vigilance, behavior and spike-wave discharges in a genetic rat model of absence epilepsy. Brain Res 2:236-244. doi: 10.1016/j.brainres.2004.01. 087 (Pubitemid 38624054)
77. Janssen PA, Niemegeers CJ, Awouters F, Schellekens KH, Megens AA, Meert TF (1988) Pharmacology of risperidone (R 64 766), a new antipsychotic with serotonin-S2 and dopamine-D2 antagonistic properties. J Pharmacol Exp Ther 244(2):685-693 (Pubitemid 18076615)
78. Jeggo RD, Kellett DO, Wang Y, Ramage AG, Jordan D (2005) The role of central 5-HT3 receptors in vagal reflex inputs to neurones in the nucleus tractus solitarius of anaesthetized rats. J Physiol 566(Pt 3):939-953. doi: 10.1113/jphysiol.2005.085845 (Pubitemid 41122673)
79. Katsurabayashi S, Kubota H, Tokutomi N, Akaike N (2003) A distinct distribution of functional presynaptic 5-HT receptor subtypes on GABAergic nerve terminals projecting to single hippocampal CA1 pyramidal neurons. Neuropharmacology 44(8):1022-1030 (Pubitemid 36570426)
80. Kawa K (1994) Distribution and functional properties of 5-HT3 receptors in the rat hippocampal dentate gyrus: a patch-clamp study. J Neurophysiol 71(5):1935-1947 (Pubitemid 24153054)
81. Kerr MP (2012) The impact of epilepsy on patients' lives. Acta Neurol Scand Suppl 194:1-9. doi: 10.1111/ane.12014
82. Kikvadze I, Foster GA (1995) Action potential-dependent output of 5-hydroxytryptamine in the anaesthetized rat amygdalopiriform cortex is strongly inhibited by tonic 5-HT1B-receptor stimulation. Brain Res 692(1-2):111-117
83. Kostowski W, Dyr W, Krzascik P (1993) The abilities of 5-HT3 receptor antagonist ICS 205-930 to inhibit alcohol preference and withdrawal seizures in rats. Alcohol 10(5):369-373 (Pubitemid 23276853)
84. Koyama S, Matsumoto N, Murakami N, Kubo C, Nabekura J, Akaike N (2002) Role of presynaptic 5-HT1A and 5-HT3 receptors in modulation of synaptic GABA transmission in dissociated rat basolateral amygdala neurons. Life Sci 72(4-5):375-387 (Pubitemid 35447763)
85. Lazarova M, Petkova B, Petkov VD (1995) Effect of dotarizine on electroconvulsive shock or pentylenetetrazol-induced amnesia and on seizure reactivity in rats. Methods Find Exp Clin Pharmacol 17(1):53-58
86. Lee KH, McCormick DA (1996) Abolition of spindle oscillations by serotonin and norepinephrine in the ferret lateral geniculate and perigeniculate nuclei in vitro. Neuron 17(2):309-321 (Pubitemid 26296157)
87. Lopez-Meraz ML, Gonzalez-Trujano ME, Neri-Bazan L, Hong E, Rocha LL (2005) 5-HT1A receptor agonists modify epileptic seizures in three experimental models in rats. Neuropharmacology 49(3):367-375. doi: 10.1016/j.neuropharm.2005. 03.020 (Pubitemid 41112824)
88. Loscher W, Czuczwar SJ (1985) Evaluation of the 5-hydroxytryptamine receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin in different rodent models of epilepsy. Neurosci Lett 60(2):201-206 (Pubitemid 16229779)
89. Lothe A, Didelot A, Hammers A, Costes N, Saoud M, Gilliam F, Ryvlin P (2008) Comorbidity between temporal lobe epilepsy and depression: a [18F] MPPF PET study. Brain 131(10):2765-2782
90. Lu KT, Gean PW (1998) Endogenous serotonin inhibits epileptiform activity in rat hippocampal CA1 neurons via 5-hydroxytryptamine1A receptor activation. Neuroscience 86(3):729-737
91. Malinowska B, Napiorkowska-Pawlak D, Pawlak R, Buczko W, Gothert M (1999) Ifenprodil influences changes in mouse behaviour related to acute and chronic ethanol administration. Eur J Pharmacol 377(1):13-19 (Pubitemid 29322752)
92. Manzke T, Preusse S, Hulsmann S, Richter DW (2008) Developmental changes of serotonin 4(a) receptor expression in the rat pre-Botzinger complex. J Comp Neurol 506(5):775-790. doi: 10.1002/cne.21581 (Pubitemid 351158306)
93. Maricq AV, Peterson AS, Brake AJ, Myers RM, Julius D (1991) Primary structure and functional expression of the 5HT3 receptor, a serotonin-gated ion channel. Science 254(5030):432-437 (Pubitemid 21917361)
94. Matthys A, Haegeman G, Van Craenenbroeck K, Vanhoenacker P (2011) Role of the 5-HT7 receptor in the central nervous system: from current status to future perspectives. Mol Neurobiol 43(3):228-253. doi: 10.1007/s12035-011-8175-3
95. McCormick DA (1992) Neurotransmitter actions in the thalamus and cerebral cortex. J Clin Neurophysiol 9(2):212-223
96. McCormick DA, Wang Z (1991) Serotonin and noradrenaline excite GABAergic neurones of the guinea-pig and cat nucleus reticularis thalami. J Physiol 442:235-255
97. McMahon LL, Kauer JA (1997) Hippocampal interneurons are excited via serotonin-gated ion channels. J Neurophysiol 78(5):2493-2502 (Pubitemid 27495476)
98. Mehta AK, Ticku MK (1993) Ethanol- and diazepam-withdrawal hyperlocomotion is not due to 5-HT3 receptor stimulation. Pharmacol Biochem Behav 45(3):755-757
99. Merlet I, Ostrowsky K, Costes N, Ryvlin P, Isnard J, Faillenot I, Lavenne F, Dufournel D, Le Bars D, Mauguiere F (2004) 5-HT1A receptor binding and intracerebral activity in temporal lobe epilepsy: an [18F]MPPF-PET study. Brain 127(Pt 4):900-913. doi: 10.1093/brain/awh109 (Pubitemid 38478534)
100. Mirski MA, Ziai WC, Chiang J, Hinich M, Sherman D (2009) Anticonvulsant serotonergic and deep brain stimulation in anterior thalamus. Seizure 18(1):64-70. doi: 10.1016/j.seizure.2008.06.011
101. Naassila M, Legrand E, d'Alche-Biree F, Daoust M (1998) Cyamemazine decreases ethanol intake in rats and convulsions during ethanol withdrawal syndrome in mice. Psychopharmacology 140(4):421-428 (Pubitemid 28566840)
102. Neuman RS, Thompson PM (1989) Serotonin mediates suppression of focal epileptiform activity induced by noxious stimulation. Epilepsia 30(3):307-313 (Pubitemid 19161392)
103. Nielsen CK (1998) Head and whole-body jerking in guinea pigs are differentially modulated by 5-HT1A, 5-HT1B/1D and 5-HT2A receptor antagonists. Eur J Pharmacol 361(2-3):185-190 (Pubitemid 29000972)
104. Obniska J, Kolaczkowski M, Bojarski AJ, Duszynska B (2006) Synthesis, anticonvulsant activity and 5-HT1A, 5-HT2A receptor affinity of new N-[(4-arylpiperazin-1-yl)-alkyl] derivatives of 2-azaspiro[4.4]nonane and [4.5]decane-1,3-dione. Eur J Med Chem 41(7):874-881. doi: 10.1016/j.ejmech.2006. 03.001 (Pubitemid 44015975)
105. O'Dell LE, Kreifeldt MJ, George FR, Ritz MC (2000a) The role of serotonin(2) receptors in mediating cocaine-induced convulsions. Pharmacol Biochem Behav 65(4):677-681 (Pubitemid 30182512)
106. O'Dell LE, Li R, George FR, Ritz MC (2000b) Molecular serotonergic mechanisms appear to mediate genetic sensitivity to cocaine-induced convulsions. Brain Res 863(1-2):213-224 (Pubitemid 30201600)
107. Ogren SO, Pakh B (1993) Effects of dopamine D1 and D2 receptor agonists and antagonists on seizures induced by chemoconvulsants in mice. Pharmacol Toxicol 72(4-5):213-220 (Pubitemid 23181599)
108. Ohno Y, Sofue N, Imaoku T, Morishita E, Kumafuji K, Sasa M, Serikawa T (2010) Serotonergic modulation of absence-like seizures in groggy rats: a novel rat model of absence epilepsy. J Pharmacol Sci 114(1):99-105
109. Okuyama S, Chaki S, Yoshikawa R, Suzuki Y, Ogawa S, Imagawa Y, Kawashima N, Ikeda Y, Kumagai T, Nakazato A, Nagamine M, Tomisawa K (1997) In vitro and in vivo characterization of the dopamine D4 receptor, serotonin 5-HT2A receptor and alpha-1 adrenoceptor antagonist (R)-(+)-2-amino-4-(4-fluorophenyl)-5-[1-[4- (4-fluorophenyl)-4-oxobutyl] pyrrolidin-3-yl]thiazole (NRA0045). J Pharmacol Exp Ther 282(1):56-63 (Pubitemid 27425526)
110. Osonoe K, Mori N, Suzuki K, Osonoe M (1994) Antiepileptic effects of inhibitors of nitric oxide synthase examined in pentylenetetrazol-induced seizures in rats. Brain Res 663(2):338-340 (Pubitemid 24339052)
111. Palfreyman MG, Schmidt CJ, Sorensen SM, Dudley MW, Kehne JH, Moser P, Gittos MW, Carr AA (1993) Electrophysiological, biochemical and behavioral evidence for 5-HT2 and 5-HT3 mediated control of dopaminergic function. Psychopharmacology 112(1 Suppl):S60-S67
112. Pape HC, McCormick DA (1989) Noradrenaline and serotonin selectively modulate thalamic burst firing by enhancing a hyperpolarization-activated cation current. Nature 340(6236):715-718. doi: 10.1038/340715a0 (Pubitemid 19214390)
113. Pappert EJ, Goetz CG, Stebbins GT, Belden M, Carvey PM (1998) 5-Hydroxytryptophan-induced myoclonus in guinea pigs: mediation through 5-HT1/2 receptor subtypes. Eur J Pharmacol 347(1):51-56 (Pubitemid 28238085)
114. Patel A, Mittal S, Manchanda S, Puliyel JM (2011) Ondansetron-induced dystonia, hypoglycemia, and seizures in a child. Ann Pharmacother 45(1):e7. doi: 10.1345/aph.1P332
115. Pehek EA, Nocjar C, Roth BL, Byrd TA, Mabrouk OS (2006) Evidence for the preferential involvement of 5-HT2A serotonin receptors in stress- and drug-induced dopamine release in the rat medial prefrontal cortex. Neuropsychopharmacology 31(2):265-277. doi: 10.1038/sj.npp.1300819 (Pubitemid 43113392)
116. Pericic D, Svob Strac D (2007) The role of 5-HT(7) receptors in the control of seizures. Brain Res 1141:48-55. doi: 10.1016/j.brainres.2007.01.019 (Pubitemid 46371399)
117. Pericic D, Lazic J, Jazvinscak Jembrek M, Svob Strac D (2005) Stimulation of 5-HT 1A receptors increases the seizure threshold for picrotoxin in mice. Eur J Pharmacol 527(1-3):105-110. doi: 10.1016/j.ejphar.2005.10.021 (Pubitemid 41745157)
118. Popa D, Cerdan J, Reperant C, Guiard BP, Guilloux JP, David DJ, Gardier AM (2010) A longitudinal study of 5-HT outflow during chronic fluoxetine treatment using a new technique of chronic microdialysis in a highly emotional mouse strain. Eur J Pharmacol 628(1-3):83-90. doi: 10.1016/j.ejphar.2009.11.037
119. Porras G, Di Matteo V, Fracasso C, Lucas G, De Deurwaerdere P, Caccia S, Esposito E, Spampinato U (2002) 5-HT2A and 5-HT2C/2B receptor subtypes modulate dopamine release induced in vivo by amphetamine and morphine in both the rat nucleus accumbens and striatum. Neuropsychopharmacology 26(3):311-324. doi: 10.1016/S0893-133X(01)00333-5 (Pubitemid 34159209)
120. Pouzet B (2002) SB-258741: a 5-HT7 receptor antagonist of potential clinical interest. CNS Drug Rev 8(1):90-100 (Pubitemid 34651317)
121. Przegalinski E, Baran L, Siwanowicz J (1994) Role of 5-hydroxytryptamine receptor subtypes in the 1-[3-(trifluoromethyl)phenyl] piperazine-induced increase in threshold for maximal electroconvulsions in mice. Epilepsia 35(4):889-894 (Pubitemid 24278048)
122. Quesney LF, Andermann F, Lal S, Prelevic S (1980) Transient abolition of generalized photosensitive epileptic discharge in humans by apomorphine, a dopamine-receptor agonist. Neurology 30(11):1169-1174 (Pubitemid 11238248)
123. Reiser G (1990) Mechanism of stimulation of cyclic-GMP level in a neuronal cell line mediated by serotonin (5-HT3) receptors. Involvement of nitric oxide, arachidonic-acid metabolism and cytosolic Ca2+. Eur J Biochem 189(3):547-552 (Pubitemid 20180427)
124. Reznic J, Staubli U (1997) Effects of 5-HT3 receptor antagonism on hippocampal cellular activity in the freely moving rat. J Neurophysiol 77(1):517-521 (Pubitemid 27053806)
125. Riazi K, Roshanpour M, Rafiei-Tabatabaei N, Homayoun H, Ebrahimi F, Dehpour AR (2006) The proconvulsant effect of sildenafil in mice: role of nitric oxide-cGMP pathway. Br J Pharmacol 147(8):935-943. doi: 10.1038/sj.bjp.0706680
126. Ritz MC, George FR (1997) Cocaine-induced convulsions: pharmacological antagonism at serotonergic, muscarinic and sigma receptors. Psychopharmacology 129(4):299-310 (Pubitemid 27092993)
127. Roberts C, Watson J, Burton M, Price GW, Jones BJ (1996) Functional characterization of the 5-HT terminal autoreceptor in the guinea-pig brain cortex. Br J Pharmacol 117(2):384-388 (Pubitemid 26030296)
128. Roberts C, Price GW, Gaster L, Jones BJ, Middlemiss DN, Routledge C (1997) Importance of h5-HT1B receptor selectivity for 5-HT terminal autoreceptor activity: an in vivo microdialysis study in the freely moving guinea-pig. Neuropharmacology 36(4-5):549-557 (Pubitemid 27272100)
129. Rocha L, Lorigados-Pedre L, Orozco-Suarez S, Morales-Chacon L, Alonso-Vanegas M, Garcia-Maeso I, Villeda-Hernandez J, Osorio-Rico L, Estupinan B, Quintana C (2007) Autoradiography reveals selective changes in serotonin binding in neocortex of patients with temporal lobe epilepsy. Prog Neuropsychopharmacol Biol Psychiatry 31(6):1208-1218. doi: 10.1016/j.pnpbp.2007. 04.014 (Pubitemid 47090174)
130. Romero L, Bel N, Artigas F, de Montigny C, Blier P (1996) Effect of pindolol on the function of pre- and post-synaptic 5-HT1A receptors: in vivo microdialysis and electrophysiological studies in the rat brain. Neuropsychopharmacology 15(4):349-360. doi: 10.1016/0893-133X(95)00240-E (Pubitemid 26342918)
131. Ropert N, Guy N (1991) Serotonin facilitates GABAergic transmission in the CA1 region of rat hippocampus in vitro. J Physiol 441:121-136
132. Routledge C, Bromidge SM, Moss SF, Price GW, Hirst W, Newman H, Riley G, Gager T, Stean T, Upton N, Clarke SE, Brown AM, Middlemiss DN (2000) Characterization of SB-271046: a potent, selective and orally active 5-HT(6) receptor antagonist. Br J Pharmacol 130(7):1606-1612. doi: 10.1038/sj.bjp. 0703457 (Pubitemid 30611938)
133. Russo E, Citraro R, Davoli A, Gallelli L, Di Paola ED, De Sarro G (2013)
134. Salgado D, Alkadhi KA (1995) Inhibition of epileptiform activity by serotonin in rat CA1 neurons. Brain Res 669(2):176-182
135. Salgado-Commissariat D, Alkadhi KA (1997) Serotonin inhibits epileptiform discharge by activation of 5-HT1A receptors in CA1 pyramidal neurons. Neuropharmacology 36(11-12):1705-1712 (Pubitemid 28085931)
136. Sargent AI, Deppe SA, Chan FA (1993) Seizure associated with ondansetron. Clin Pharm 12(8):613-615 (Pubitemid 23213479)
137. Sarnyai Z, Sibille EL, Pavlides C, Fenster RJ, McEwen BS, Toth M (2000) Impaired hippocampal-dependent learning and functional abnormalities in the hippocampus in mice lacking serotonin(1A) receptors. Proc Natl Acad Sci USA 97(26):14731-14736. doi: 10.1073/pnas.97.26.14731 (Pubitemid 32016644)
138. Savic I, Lindstrom P, Gulyas B, Halldin C, Andree B, Farde L (2004) Limbic reductions of 5-HT1A receptor binding in human temporal lobe epilepsy. Neurology 62(8):1343-1351 (Pubitemid 38526047)
139. Scorza MC, Llado-Pelfort L, Oller S, Cortes R, Puigdemont D, Portella MJ, Perez-Egea R, Alvarez E, Celada P, Perez V, Artigas F (2012) Preclinical and clinical characterization of the selective 5-HT(1A) receptor antagonist DU-125530 for antidepressant treatment. Br J Pharmacol 167(5):1021-1034. doi: 10.1111/j.1476-5381.2011.01770.x
140. Semenova TP, Ticku MK (1992) Effects of 5-HT receptor antagonists on seizure susceptibility and locomotor activity in DBA/2 mice. Brain Res 588(2):229-236
141. Semenova TP, Tiku MK (1997) Interactions between the serotoninergic and noradrenergic systems of the brain and their role in the regulation of animal behavior. Neurosci Behav Physiol 27(3):280-282 (Pubitemid 127723157)
142. Sevoz C, Nosjean A, Callera JC, Machado B, Hamon M, Laguzzi R (1996) Stimulation of 5-HT3 receptors in the NTS inhibits the cardiac Bezold-Jarisch reflex response. Am J Physiol 271(1 Pt 2):H80-H87
143. Sharma A, Raina V (2001) Generalised seizures following ondansetron. Ann Oncol 12(1):131-132
144. Sharp T, Umbers V, Gartside SE (1997) Effect of a selective 5-HT reuptake inhibitor in combination with 5-HT1A and 5-HT1B receptor antagonists on extracellular 5-HT in rat frontal cortex in vivo. Br J Pharmacol 121(5):941-946. doi: 10.1038/sj.bjp.0701235 (Pubitemid 27277788)
145. Singh NN, Rai A, Selhorst JB, Acharya JN (2009) Ondansetron and seizures. Epilepsia 50(12):2663-2666. doi: 10.1111/j.1528-1167.2009.02139.x
146. Sisodiya SM, Lin WR, Harding BN, Squier MV, Thom M (2002) Drug resistance in epilepsy: expression of drug resistance proteins in common causes of refractory epilepsy. Brain 125(Pt 1):22-31 (Pubitemid 34084034)
147. Slaten ER, Hernandez MC, Albay R 3rd, Lavian R, Janusonis S (2010) Transient expression of serotonin 5-HT4 receptors in the mouse developing thalamocortical projections. Dev Neurobiol 70(3):165-181. doi: 10.1002/dneu.20775
148. Starr MS (1996) The role of dopamine in epilepsy. Synapse 22(2):159-194. doi: 10.1002/(SICI)1098-2396(199602)22:2<159::AID-SYN8>3.0.CO;2-C (Pubitemid 26041233)
149. Staubli U, Xu FB (1995) Effects of 5-HT3 receptor antagonism on hippocampal theta rhythm, memory, and LTP induction in the freely moving rat. J Neurosci 15(3 Pt 2):2445-2452
150. Stean TO, Atkins AR, Heidbreder CA, Quinn LP, Trail BK, Upton N (2005) Postsynaptic 5-HT1B receptors modulate electroshock-induced generalised seizures in rats. Br J Pharmacol 144(5):628-635. doi: 10.1038/sj.bjp.0706027 (Pubitemid 40445610)
151. Tecott LH, Maricq AV, Julius D (1993) Nervous system distribution of the serotonin 5-HT3 receptor mRNA. Proc Natl Acad Sci USA 90(4):1430-1434 (Pubitemid 23058186)
152. Tecott LH, Sun LM, Akana SF, Strack AM, Lowenstein DH, Dallman MF, Julius D (1995) Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors. Nature 374(6522):542-546. doi: 10.1038/374542a0
153. Than M, Kocsis P, Tihanyi K, Fodor L, Farkas B, Kovacs G, Kis-Varga A, Szombathelyi Z, Tarnawa I (2007) Concerted action of antiepileptic and antidepressant agents to depress spinal neurotransmission: possible use in the therapy of spasticity and chronic pain. Neurochem Int 50(4):642-652. doi: 10.1016/j.neuint.2006.12.008 (Pubitemid 46343681)
154. Theodore WH, Hasler G, Giovacchini G, Kelley K, Reeves-Tyer P, Herscovitch P, Drevets W (2007) Reduced hippocampal 5HT1A PET receptor binding and depression in temporal lobe epilepsy. Epilepsia 48(8):1526-1530. doi: 10.1111/j.1528-1167.2007.01089.x (Pubitemid 47245794)
155. Theodore WH, Wiggs EA, Martinez AR, Dustin IH, Khan OI, Appel S, Reeves-Tyer P, Sato S (2012) Serotonin 1A receptors, depression, and memory in temporal lobe epilepsy. Epilepsia 53(1):129-133. doi: 10.1111/j.1528-1167.2011. 03309.x
156. Toczek MT, Carson RE, Lang L, Ma Y, Spanaki MV, Der MG, Fazilat S, Kopylev L, Herscovitch P, Eckelman WC, Theodore WH (2003) PET imaging of 5-HT1A receptor binding in patients with temporal lobe epilepsy. Neurology 60(5):749-756 (Pubitemid 36297355)
157. Tokarski K, Zahorodna A, Bobula B, Hess G (2002) Comparison of the effects of 5-HT1A and 5-HT4 receptor activation on field potentials and epileptiform activity in rat hippocampus. Exp Brain Res 147(4):505-510. doi: 10.1007/s00221-002-1259-6 (Pubitemid 35440503)
158. Tuerke KJ, Limebeer CL, Fletcher PJ, Parker LA (2012) Double dissociation between regulation of conditioned disgust and taste avoidance by serotonin availability at the 5-HT(3) receptor in the posterior and anterior insular cortex. J Neurosci 32(40):13709-13717. doi: 10.1523/JNEUROSCI.2042-12.2012
159. Turski L, Cavalheiro EA, Bortolotto ZA, Ikonomidou-Turski C, Kleinrok Z, Turski WA (1988) Dopamine-sensitive anticonvulsant site in the rat striatum. J Neurosci 8(11):4027-4037 (Pubitemid 19017389)
160. Upton N, Stean T, Middlemiss D, Blackburn T, Kennett G (1998) Studies on the role of 5-HT2C and 5-HT2B receptors in regulating generalised seizure threshold in rodents. Eur J Pharmacol 359(1):33-40 (Pubitemid 28515719)
161. Van Oekelen D, Megens A, Meert T, Luyten WH, Leysen JE (2003) Functional study of rat 5-HT2A receptors using antisense oligonucleotides. J Neurochem 85(5):1087-1100 (Pubitemid 36613257)
162. Velazquez JL, Huo JZ, Dominguez LG, Leshchenko Y, Snead OC 3rd (2007) Typical versus atypical absence seizures: network mechanisms of the spread of paroxysms. Epilepsia 48(8):1585-1593. doi: 10.1111/j.1528-1167.2007.01120.x (Pubitemid 47245805)
163. Velisek L, Bohacenkova L, Capkova M, Mares P (1994) Clonidine, but not ritanserin, suppresses kainic acid-induced automatisms in developing rats. Physiol Behav 55(5):879-884
164. Wada Y, Hasegawa H, Nakamura M, Yamaguchi N (1992a) Behavioral and electroencephalographic effects of a serotonin receptor agonist (5-methoxy-N, N-dimethyltryptamine) in a feline model of photosensitive epilepsy. Neurosci Lett 138(1):115-118
165. Wada Y, Nakamura M, Hasegawa H, Yamaguchi N (1992b) Role of serotonin receptor subtype in seizures kindled from the feline hippocampus. Neurosci Lett 141(1):21-24
166. Wada Y, Nakamura M, Hasegawa H, Yamaguchi N (1993) Intra-hippocampal injection of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) inhibits partial and generalized seizures induced by kindling stimulation in cats. Neurosci Lett 159(1-2):179-182 (Pubitemid 23283268)
167. Wada Y, Shiraishi J, Nakamura M, Koshino Y (1997a) Effects of the 5-HT3 receptor agonist 1-(m-chlorophenyl)-biguanide in the rat kindling model of epilepsy. Brain Res 759(2):313-316 (Pubitemid 27291536)
168. Wada Y, Shiraishi J, Nakamura M, Koshino Y (1997b) Role of serotonin receptor subtypes in the development of amygdaloid kindling in rats. Brain Res 747(2):338-342 (Pubitemid 27077411)
169. Wada Y, Hirao N, Shiraishi J, Nakamura M, Koshino Y (1999) Action of the selective 5-HT4 receptor antagonist SB 204070A in the rat kindling model of epilepsy. Neurosci Res Commun 25(1):43-49 (Pubitemid 29395049)
170. Waeber C, Sebben M, Nieoullon A, Bockaert J, Dumuis A (1994) Regional distribution and ontogeny of 5-HT4 binding sites in rodent brain. Neuropharmacology 33(3-4):527-541 (Pubitemid 24168725)
171. Waeber C, Sebben M, Bockaert J, Dumuis A (1996) Regional distribution and ontogeny of 5-HT4 binding sites in rat brain. Behav Brain Res 73(1-2):259-262 (Pubitemid 26008792)
172. Watanabe K, Minabe Y, Ashby CR Jr, Katsumori H (1998) Effect of acute administration of various 5-HT receptor agonists on focal hippocampal seizures in freely moving rats. Eur J Pharmacol 350(2-3):181-188 (Pubitemid 28294044)
173. Watanabe K, Ashby CR Jr, Katsumori H, Minabe Y (2000) The effect of the acute administration of various selective 5-HT receptor antagonists on focal hippocampal seizures in freely-moving rats. Eur J Pharmacol 398(2):239-246 (Pubitemid 30333350)
174. Weinshenker D, Szot P (2002) The role of catecholamines in seizure susceptibility: new results using genetically engineered mice. Pharmacol Ther 94(3):213-233 (Pubitemid 34759986)
175. Welsh JP, Placantonakis DG, Warsetsky SI, Marquez RG, Bernstein L, Aicher SA (2002) The serotonin hypothesis of myoclonus from the perspective of neuronal rhythmicity. Adv Neurol 89:307-329
176. Wesolowska A, Nikiforuk A, Chojnacka-Wojcik E (2006) Anticonvulsant effect of the selective 5-HT1B receptor agonist CP 94253 in mice. Eur J Pharmacol 541(1-2):57-63. doi: 10.1016/j.ejphar.2006.04.049 (Pubitemid 44192370)
177. Witkin JM, Baez M, Yu J, Barton ME, Shannon HE (2007) Constitutive deletion of the serotonin-7 (5-HT(7)) receptor decreases electrical and chemical seizure thresholds. Epilepsy Res 75(1):39-45. doi: 10.1016/j.eplepsyres.2007. 03.017 (Pubitemid 46856117)
178. Yang Z, Liu X, Yin Y, Sun S, Deng X (2012) Involvement of 5-HT(7) receptors in the pathogenesis of temporal lobe epilepsy. Eur J Pharmacol 685(1-3):52-58. doi: 10.1016/j.ejphar.2012.04.011
179. Zhuang X, Gross C, Santarelli L, Compan V, Trillat AC, Hen R (1999) Altered emotional states in knockout mice lacking 5-HT1A or 5-HT1B receptors. Neuropsychopharmacology 21(2 Suppl):52S-60S. doi: 10.1016/S0893-133X(99)00047-0 (Pubitemid 29396471)